Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|February 21, 1996
The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistryS Sjögren, M Inganäs, T Norberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trialG Liljegren, L Holmberg, J Bergh, et al.
Anticancer Research|August 23, 2000
Human milk fat globule antigen 1 (HMFG1) expression in prostatic carcinoma and immunotargeting with a radiolabelled monoclonal anti-HMFG1 antibodyG Ljung, B Lennernäs, H Nordgren, et al.
Oncology Reports|November 27, 2010
EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapyQ Wei, Y Shui, S Zheng, et al.
British Journal of Cancer|May 20, 2004
HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature reviewJ Carlsson, H Nordgren, J Sjöström, et al.
Veterinary Microbiology|May 18, 2022
Mechanisms behind the varying severity of Aleutian mink disease virus: Comparison of three farms with a different disease statusJ Virtanen, K Aaltonen, A-M Moisander-Jylhä, et al.
Gynecologic Oncology|May 1, 1987
Automatic analysis of Papanicolaou smears by digital image processingB Stenkvist, R Bergström, U Brinne, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Modal DNA values and estramustine-binding protein (EMBP) as prognostic markers in prostatic cancerH Nordgren, S Nilsson, S Eklöv, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Overview on human breast cancer with focus on prognostic and predictive factors with special attention on the tumour suppressor gene p53T Norberg, T Jansson, S Sjøgren, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2006
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trialA Ringberg, H Nordgren, S Thorstensson, et al.
Pageof 5